Global Melanoma Therapeutics Market
MarketDataForecast.com published a new research report on Global Melanoma Therapeutics Market that gives detailed information on Market Size and Growth
MarketDataForecast.com published a new research report on Global Melanoma Therapeutics Market that gives detailed information on Market Size and Growth
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
RESEARCH REPORT<br />
APRIL 2017<br />
GLOBAL MELANOMA THERAPEUTICS MARKET<br />
SEGMENTED BY TYPE AND SIZE, INDUSTRY ANALYSIS, SIZE,<br />
SHARE, GROWTH TRENDS AND FORECASTS 2016-2021
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
According to the report "<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong> ", published by <strong>Market</strong><br />
Data Forecast, the global market is projected to reach USD 4.63 billion by 2021, at a CAGR of<br />
15.80% from 2016 to 2021.<br />
The market for skin diseases and treatment is expanding substantially due to the mounting<br />
frequency of skin ailments such as skin cancer, skin infections, and skin allergies.<br />
<strong>Melanoma</strong> denotes to the type of skin cancer which forms from the pigment-consisting cells<br />
in the skin. It is more frequent in places with a sunny environment and is the most dangerous<br />
of all skin cancers. UV radiations are the main causes of melanoma. However, genes can also<br />
lead to melanoma. Even though, a plethora of treatment choices are accessible today, various<br />
immunotherapies and combination therapies are anticipated to arrive in the market. Large<br />
acceptance of these new treatments is projected due to their enhanced survival benefits and<br />
negligible side effects.<br />
Factors such as rise in melanoma cases, increasing awareness, high acceptance rate of<br />
therapeutics among patients, and government policies to provide better care for melanoma<br />
drive the growth of the <strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong>.<br />
The <strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> market is segmented based on cancer stage, cancer<br />
type, diagnosis and treatment.<br />
1) Based on cancer stage:<br />
Stage 0<br />
Stage I<br />
Stage II<br />
Stage III<br />
Stage IV<br />
2) Based on cancer type:<br />
<br />
<br />
<br />
<br />
<br />
<br />
Nodular melanoma<br />
Acral lentiginous melanoma<br />
Superficial spreading melanoma<br />
Lentigno maligna melanoma<br />
Amelanotic melanoma<br />
Others<br />
3) Based on diagnosis:<br />
<br />
<br />
<br />
<br />
<br />
<br />
Ultrasound<br />
Blood Tests<br />
Dermatoscopy<br />
Sentinel lymph node biopsy<br />
X-rays<br />
CT Scan<br />
4) Based on treatment:<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
<br />
<br />
Early melanoma<br />
Advanced melanoma<br />
a) Biological therapy<br />
b) Targeted therapy<br />
c) Surgery<br />
d) Chemotherapy<br />
e) Radiotherapy<br />
f) Immune therapy<br />
5) Geographical Segmentation:<br />
<br />
<br />
<br />
<br />
<br />
North America<br />
Europe<br />
Asia-Pacific<br />
Latin America<br />
Middle East and Africa<br />
The major companies operating in the global <strong>Melanoma</strong> <strong>Therapeutics</strong> market are Bristol-<br />
Myers Squibb Co., Merck and Co., F. Hoffmann-La Roche, Amgen Inc., Celgene Corp, Daiichi<br />
Sankyo, and Pfizer Inc.<br />
TABLE OF CONTENTS<br />
1. Introduction<br />
1.1 <strong>Market</strong> Definition<br />
1.2 Study Deliverables<br />
1.3 Base Currency, Base Year and Forecast Periods<br />
1.4 General Study Assumptions<br />
2. Research Methodology<br />
3. Overview<br />
2.1 Introduction<br />
2.2 Research Phases<br />
2.2.1 Secondary Research<br />
2.2.2 Primary Research<br />
2.2.3 Econometric Modelling<br />
2.2.4 Expert Validation<br />
2.3 Analysis Design<br />
2.4 Study Timeline<br />
3.1 Executive Summary<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
3.2 Key Inferences<br />
3.3 New Developments<br />
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)<br />
View report at http://www.marketdataforecast.com/market-reports/global-melanomatherapeutics-market-850/<br />
4.1 <strong>Market</strong> Drivers<br />
4.2 <strong>Market</strong> Restraints<br />
4.3 Key Challenges<br />
4.4 Current Opportunities in the <strong>Market</strong><br />
5. <strong>Market</strong> Segmentation<br />
5.1 By cancer stage<br />
5.1.1 Stage 0<br />
5.1.2 Stage I<br />
5.1.3 Stage II<br />
5.1.4 Stage III<br />
5.1.5 Stage IV<br />
Free sample of the report is available at http://www.marketdataforecast.com/marketreports/global-melanoma-therapeutics-market-850/request-sample<br />
5.2 By cancer type<br />
5.2.1 Nodular melanoma<br />
5.2.2 Acral lentiginous melanoma<br />
5.2.3 Superficial spreading melanoma<br />
5.2.4 Lentigno maligna melanoma<br />
5.2.5 Amelanotic melanoma<br />
5.2.6 Others<br />
5.3 By Diagnosis<br />
5.3.1 Ultrasound<br />
5.3.2 Blood Tests<br />
5.3.3 Dermatoscopy<br />
5.3.4 Sentinel lymph node biopsy<br />
5.3.5 X-rays<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
5.3.6 CT Scan<br />
5.4 By Treatment<br />
6. Geographical Analysis<br />
5.4.1 Early melanoma<br />
5.4.2 Advanced melanoma<br />
6.1 North America<br />
6.2 Europe<br />
5.4.2.1 Biological therapy<br />
5.4.2.2 Targeted therapy<br />
5.4.2.3 Surgery<br />
5.4.2.4 Chemotherapy<br />
5.4.2.5 Radiotherapy<br />
5.4.2.6 Immune therapy<br />
6.1.1 Introduction<br />
6.1.2 United States<br />
6.1.3 Canada<br />
6.2.1 Introduction<br />
Request Customization at http://www.marketdataforecast.com/market-reports/globalmelanoma-therapeutics-market-850/customize-report<br />
6.2.2 U.K<br />
6.2.3 Spain<br />
6.2.4 Germany<br />
6.2.5 Italy<br />
6.2.6 France<br />
6.3 Asia-Pacific<br />
Enquire more about the report at http://www.marketdataforecast.com/marketreports/global-melanoma-therapeutics-market-850/inquire<br />
6.3.1 Introduction<br />
6.3.2 China<br />
6.3.3 India<br />
6.3.4 Japan<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
6.3.5 South Korea<br />
6.3.6 Australia<br />
6.4 Latin America<br />
6.4.1 Introduction<br />
6.4.2 Brazil<br />
6.4.3 Argentina<br />
6.4.4 Mexico<br />
6.4.5 Rest of Latin America<br />
6.5 Middle East & Africa<br />
6.5.1 Introduction<br />
6.5.2 Middle-East<br />
6.5.3 Africa<br />
7. Pipeline Product Analysis<br />
Buy this report at https://www.marketdataforecast.com/cart/buy-now/globalmelanoma-therapeutics-market-850<br />
7.1 Overview<br />
7.2 Pipeline Development Landscape<br />
7.3 Molecular Targets in the Pipeline<br />
7.4 Clinical Trials<br />
7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and<br />
Molecular Target<br />
7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule<br />
Type and Molecular Target<br />
7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type<br />
and Molecular Target.<br />
8. Strategic Analysis<br />
8.1 PESTLE analysis<br />
8.1.1 Political<br />
8.1.2 Economic<br />
8.1.3 Social<br />
8.1.4 Technological<br />
8.1.5 Legal<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
8.1.6 Environmental<br />
8.2 Porter’s Five analysis<br />
8.2.1 Bargaining Power of Suppliers<br />
8.2.2 Bargaining Power of Consumers<br />
8.2.3 Threat of New Entrants<br />
8.2.4 Threat of Substitute Products and Services<br />
8.2.5 Competitive Rivalry within the Industry<br />
9. <strong>Market</strong> Leaders' Analysis<br />
9.1 Bristol-Myers Squibb Co<br />
9.1.1 Overview<br />
9.1.2 Product Analysis<br />
9.1.3 Strategic Evaluation and Operations<br />
9.1.4 Financial analysis<br />
9.1.5 Legal issues<br />
9.1.6 Recent Developments<br />
9.1.7 SWOT analysis<br />
9.1.8 Analyst View<br />
9.2 Merck and Co<br />
9.3 F. Hoffmann-La Roche<br />
9.4 Amgen Inc<br />
9.5 Celgene Corp<br />
9.6 Daiichi Sankyo<br />
9.7 Pfizer Inc<br />
10. Competitive Landscape<br />
10.1 <strong>Market</strong> share analysis<br />
10.2 Merger and Acquisition Analysis<br />
10.3 Agreements, collaborations and Joint Ventures<br />
10.4 New Product Launches<br />
11. Expert Opinions<br />
11.1 <strong>Market</strong> Outlook<br />
11.2 Investment Opportunities<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
Appendix<br />
a) List of Tables<br />
b) List of Figures<br />
SCOPE OF THE REPORT<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<strong>Global</strong>, regional and country-level analysis and forecasts of the study market;<br />
providing Insights on the major countries/regions in which this industry is blooming<br />
and to also identify the regions that are still untapped<br />
Segment-level analysis in terms of technology, component, and type along with<br />
market size forecasts and estimations to detect key areas of industry growth in detail<br />
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the<br />
market and their impact on shifting market dynamics<br />
Study of the effect of exogenous and endogenous factors that affect the global<br />
market; which includes broadly demographic, economics, and political, among other<br />
macro-environmental factors presented in an extensive PESTLE Analysis<br />
Study the micro environment factors that determine the overall profitability of an<br />
Industry, using Porter’s five forces analysis for analyzing the level of competition and<br />
business strategy development<br />
A comprehensive list of key market players along with their product portfolio, current<br />
strategic interests, key financial information, legal issues, SWOT analysis and analyst<br />
overview to study and sustain the market environment<br />
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in<br />
the field along with new product launches, comparative financial studies and recent<br />
developments in the market by the major companies<br />
An executive summary, abridging the entire report in such a way that decision-making<br />
personnel can rapidly become acquainted with background information, concise<br />
analysis and main conclusions<br />
Expertly devised analyst overview along with Investment opportunities to provide<br />
both individuals and organizations a strong financial foothold in the market<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
ABOUT US<br />
<strong>Market</strong> Data Forecast is a firm working in the areas of market research<br />
and business intelligence. We have rich experience in research across<br />
various business domains and we cater to the needs of both individual<br />
and corporate clients. Our research services assist clients in key<br />
business areas like business process improvement, key decision<br />
making and developing appropriate corporate strategy. We are truly<br />
committed to our clients and other stakeholders for providing<br />
customized research services of the highest quality.<br />
CONTACT INFORMATION<br />
We always look forward to working with new clients, pushing our<br />
boundaries and extending our reach beyond global horizons. Get in<br />
touch with us for further queries.<br />
Website: www.marketdataforecast.com<br />
E-Mail: contact@marketdataforecast.com<br />
Phone: +1 888-702-9626 (U.S Toll free),<br />
+91 7680952236 (Indian Office).<br />
FOR MORE INFORMATION<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
Change language